HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nimodipine promotes regeneration of peripheral facial nerve function after traumatic injury following maxillofacial surgery: an off label pilot-study.

AbstractBACKGROUND:
Animal tests, retro- and prospective clinical trials in neurosurgical departments have shown a beneficial effect of nimodipine on the preservation and recovery of facial and acoustic nerve function following vestibular schwannoma surgery. Encouraged by these positive results a pilot-study of nimodipine treatment in patients with a peripheral facial nerve (FN) paresis following maxillofacial surgery was performed. The rate and time of FN recovery were analysed and compared with the results in the literature.
METHODS:
Thirteen patients (n = 13) suffering from a moderate (1/13) up to a severe (12/13) peripheral FN paresis after maxillofacial surgery were treated with orally administered nimodipine. The anatomical main course of the FN was preserved in all patients with a 2nd to 3rd degree of Sunderland-injury (Sunderland, 1951). After no evidence of a spontaneous regeneration had shown, oral medication with nimodipine was started as an "off-label" use.
RESULTS:
An improvement of the FN function correlated to the start of the vasoactive medication and as a consequence a recovery of the FN function up to House-Brackmann (HB) grade I°-II° was observed in all the patients within a period of 2 months after the beginning of treatment (p = 0.00027).
CONCLUSIONS:
The clinical observations in these patients suggest a positive effect of nimodipine on the acceleration of peripheral FN regeneration after surgically caused trauma. The results of this pilot-study are very promising. A prospective study with a larger number of patients is planned to approve the beneficial effect of nimodipine on the peripheral FN in maxillofacial or otorhinolaryngological surgery.
AuthorsK Scheller, C Scheller
JournalJournal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery (J Craniomaxillofac Surg) Vol. 40 Issue 5 Pg. 427-34 (Jul 2012) ISSN: 1878-4119 [Electronic] Scotland
PMID21885293 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2011 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
Chemical References
  • Vasodilator Agents
  • Nimodipine
Topics
  • Adolescent
  • Adult
  • Aged
  • Facial Bones (injuries)
  • Facial Nerve (drug effects)
  • Facial Nerve Injuries (drug therapy, etiology)
  • Facial Paralysis (drug therapy, etiology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Mandibular Condyle (injuries)
  • Mandibular Fractures (surgery)
  • Middle Aged
  • Muscle Weakness (drug therapy)
  • Nerve Regeneration (drug effects)
  • Nimodipine (therapeutic use)
  • Off-Label Use
  • Oral Surgical Procedures (adverse effects)
  • Osteotomy, Sagittal Split Ramus (adverse effects)
  • Parotid Diseases (surgery)
  • Parotid Neoplasms (surgery)
  • Pilot Projects
  • Postoperative Complications
  • Prognathism (surgery)
  • Recovery of Function (drug effects)
  • Skull Fractures (surgery)
  • Vasodilator Agents (therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: